Sign in

CIK 0000906709

  • Non-accelerated filer
  • Smaller reporting company

NEKTAR THERAPEUTICS

Sign in to watch
Ticker
NKTR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943134940
Phone
+1 415-482-5300
Business address
455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
Former names
INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2016-02-16 ROBIN HOWARD W President & CEO Returned to the company · Restricted Stock Unit −5,625 61,875
2016-02-16 Doberstein Stephen K SVP & Chief Scientific Officer Exercise or conversion +875 $0.00 $0 875
2016-02-16 Doberstein Stephen K SVP & Chief Scientific Officer Returned to the company · Restricted Stock Unit −875 9,625
2016-02-16 Thomsen Jillian B. SVP & Chief Accounting Officer Exercise or conversion +1,875 $0.00 $0 5,874
2016-02-16 Thomsen Jillian B. SVP & Chief Accounting Officer Returned to the company · Restricted Stock Unit −1,875 20,625
2016-02-16 Labrucherie Gil M SVP & General Counsel Exercise or conversion +2,166 $0.00 $0 7,417
2016-02-16 Labrucherie Gil M SVP & General Counsel Returned to the company · Restricted Stock Unit −2,166 23,834
2016-02-16 Hora Maninder SVP Pharma Dev & Mfg Ops Exercise or conversion +2,166 $0.00 $0 6,766
2016-02-16 Hora Maninder SVP Pharma Dev & Mfg Ops Returned to the company · Restricted Stock Unit −2,166 23,834
2016-02-10 Labrucherie Gil M SVP & General Counsel Exercise or conversion +11,666 $6.46 $75K 16,917
2016-02-10 Labrucherie Gil M SVP & General Counsel Sale −11,666 $11.49 $134K 5,251
2016-02-10 Labrucherie Gil M SVP & General Counsel Exercise or conversion · Stock Option −11,666 0
2016-02-10 Thomsen Jillian B. SVP & Chief Accounting Officer Exercise or conversion +15,000 $6.65 $100K 18,999
2016-02-10 Thomsen Jillian B. SVP & Chief Accounting Officer Sale −15,000 $11.49 $172K 3,999
2016-02-10 Thomsen Jillian B. SVP & Chief Accounting Officer Exercise or conversion · Stock Option −15,000 15,000
2016-02-10 ROBIN HOWARD W President & CEO Exercise or conversion +66,666 $6.46 $431K 76,666
2016-02-10 ROBIN HOWARD W President & CEO Sale −66,666 $11.49 $766K 10,000
2016-02-10 ROBIN HOWARD W President & CEO Exercise or conversion · Stock Option −66,666 0
2016-02-03 Gergel Ivan P. SVP & Chief Medical Officer Grant or award · Stock Option +100,000 100,000
2016-01-20 Lingnau Lutz Director Exercise or conversion +15,000 $5.15 $77K 31,450

Page 54 of 55 · 1,088 trades